Reaction #157984
ord-33004f25daeb4eaa95b6c15a34f6c655
Reaction equation
Reactants
Reagents
Solvents
Conditions
Workup
- 1OtherThe aqueous phase is removed
- 2Extractionextracted with ethyl acetate
- 3DryingThe combined organic phases are dried over sodium sulfate
- 4FiltrationThe solids are filtered off
- 5workup.DISTILLATIONthe solvent is distilled off
- 6OtherThe residue is purified by chromatography
Procedure
To a solution of 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylic acid (E, 160 mg) in dichloromethane (5 ml) are added, at room temperature, 2-chlorocyclohexanol (57 mg), 4-dimethylaminopyridine (4 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (94 mg). The mixture is stirred overnight, and water is then added. The aqueous phase is removed and extracted with ethyl acetate. The combined organic phases are dried over sodium sulfate. The solids are filtered off and the solvent is distilled off. The residue is purified by chromatography. This gives 2-chlorocyclohexyl 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazole-5-carboxylate (100 mg, 50%).